RALEIGH, N.C. & TARRYTOWN, N.Y.-- --Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals, Inc. announced today that the submission to the European Medicines Agency of RELISTORA Subcutaneous Injection for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, has been accepted for review.
http://ift.tt/1f0U7x8
http://ift.tt/1f0U7x8
No comments:
Post a Comment